Metamizole modulates the concentrations of cytokines and hematopoietic growth factors in an experimental model of depression

Basit Öğe Kaydı
dc.contributor.authorMaytalman, Erkan
dc.contributor.authorKıroğlu, Olcay
dc.contributor.authorBerktaş, Fatih
dc.contributor.authorSamur, Dilara Nemutlu
dc.contributor.authorAksu, Fazılet
dc.date.accessioned2026-01-24T12:01:10Z
dc.date.available2026-01-24T12:01:10Z
dc.date.issued2025
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractObjective: In recent years, evidence of antidepressant-like activity of non-steroidal anti-inflammatory drugs has been presented. Furthermore, associations between cytokines, which are important components of the immune system, as well as hematopoietic growth factors and depression have also been demonstrated. In this study, it was aimed to analyze the effect of metamizole on the expression of cytokines and hematopoietic growth factors in mice exposed to unpredictable stress models. Method: In order to develop chronic depression behaviors, an unpredictable chronic mild stress model was applied to mice. The depression group was not given any drug and other groups were given 100 and 200 mg/kg metamizole. Forced swimming test was performed to evaluate the effect of metamizole against depression. Relative concentrations of interleukin-1 alpha (IL-1?), IL-1 beta (IL-1-ß), IL-2, IL-4, IL-6, IL-10, IL-12, IL-17, Interferon gamma (IFN-?)-, tumor necrosis factor-alpha (TNF-?), Granulocyte-colony-stimulating factor (G-CSF), and Granulocyte-macrophage colony-stimulating factor (GM-CSF) were analyzed in serum samples of animals with semi-quantitative ELISA. Results: In the forced swimming test, the immobility time of the depression group significantly increased compared to the control group. The immobility time of groups treated with metamizole significantly decreased compared to the depression group and approached the control. Significant decreases were observed in the relative concentration levels of cytokines and hematopoietic growth factors in the groups treated with 100 and/or 200 mg/kg metamizole compared to the depression group except for IL-1?, IL-4, and IL-10. Conclusion: Evidence showing the contribution of COX enzymes to the pathophysiology of depression is increasing. In this context, the results indicate that metamizole, which can inhibit both isoforms of COX, may cause changes in cytokine levels and hematopoietic growth factors in a depression model. However, more controlled clinical studies are needed.
dc.identifier.doi10.17944/interdiscip.1687684
dc.identifier.endpage108
dc.identifier.issn2980-1915
dc.identifier.issue55
dc.identifier.startpage100
dc.identifier.trdizinid1334577
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1334577
dc.identifier.urihttps://doi.org/10.17944/interdiscip.1687684
dc.identifier.urihttps://hdl.handle.net/20.500.12868/4060
dc.identifier.volume16
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofInterdisciplinary medical journal
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20260121
dc.subjectDepression
dc.subjectcytokines
dc.subjectnon-steroidal anti-inflammatory drugs
dc.subjectMetamizole
dc.subjecthematopoietic growth factors
dc.titleMetamizole modulates the concentrations of cytokines and hematopoietic growth factors in an experimental model of depression
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu